Table 2 Relationship between the continuation of anti-TNFα agent and CRP levels
From: Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease
At week 8 | At week 48 | |||||
|---|---|---|---|---|---|---|
Continuation | Discontinuation | p value | Continuation | Discontinuation | p value | |
N (%) | 25 (86.2) | 4 (13.8) | 22 (75.9) | 7 (24.1) | ||
CRP level at baseline (mean ± SD, mg/dl) | 1.16 ± 2.09 | 5.93 ± 8.60 | 0.017 | 0.84 ± 1.41 | 4.86 ± 6.80 | 0.006 |
CRP ≥ 1 mg/dL in the group (%) | 9 (36.0) | 2 (50.0) | 6 (27.3) | 5 (71.4) | ||